🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shuai Wang

Central South University

ORCID: 0000-0003-0718-1820

Also affiliated with Institute of Catalysis and Petrochemistry, Advanced Energy Materials (United States), Chemical Synthesis Lab

MedicineImmunology and MicrobiologyChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor.

36 citations

Qiu‐Xu Teng, Shuai Wang, Zi‐Ning Lei, Huihui Hu, Huifang Lv +9 more

5 citations

Lichong Gong, Georges El Fakhri, Junfeng Wang, Shuai Wang

4 citations

Sara Haddock, Shuai Wang, Hediye Erdjument‐Bromage, Wenke Liu, Niklas Ravn-Boess +9 more